Why have AIM's multiple mRNA vaccines been able to push for FDA approval in such a short time? First, innovation is in AIM's DNA. The mRNA shingles vaccine, currently submitted for U.S. clinical ...

Separately, FDA employees got an email Monday from Sara Brenner, the FDA's acting commissioner, that Kyle Diamantas, a lawyer ...

ADHD Advisor examined data from the Drug Enforcement Administration and other sources to see why the Adderall shortage ...

Patrizia Cavazzoni, the former director of the Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research, ...

Hims & Hers said on Monday that it may no longer be able to sell compounded versions of the weight-loss drug made by Novo ...

The reversal is the latest example of President Donald Trump and billionaire Elon Musk’s chaotic approach to cost-cutting, ...